Details
Stereochemistry | ACHIRAL |
Molecular Formula | CO2 |
Molecular Weight | 44.0095 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C=O
InChI
InChIKey=CURLTUGMZLYLDI-UHFFFAOYSA-N
InChI=1S/CO2/c2-1-3
Molecular Formula | CO2 |
Molecular Weight | 44.0095 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Carbon dioxide is a colorless gas occurring naturally in Earth's atmosphere. Carbon dioxide is a primary carbon source for life on Earth. It is produced by all aerobic organisms during metabolism of carbohydrates and lipids. Carbon dioxide is used in food industry as an acidity regulator and for production of carbonated soft drinks and soda water. In medicine, carbon dioxide is commonly used as an insufflation gas for minimally invasive surgery (laparoscopy, endoscopy, and arthroscopy) to enlarge and stabilize body cavities to provide better visibility of the surgical area. A mixture of carbon dioxide and oxygen is used for stimulation of breathing after apnea, in anesthetic procedures to increase the depth of respiration, to facilitate blind intubations in anesthetic practice.
CNS Activity
Sources: https://www.boconline.co.uk/internet.lg.lg.gbr/en/images/medical_carbon_dioxide410_56027.pdf?v=2.0
Curator's Comment: Carbon dioxide is naturally produced in all tissues.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseCarbon dioxide is used to stimulate respiration after a period of apnoea |
|||
Primary | Unknown Approved UseCarbon dioxide is used in chronic respiratory obstruction after it has been relieved |
|||
Palliative | Unknown Approved UseCarbon dioxide is used to increase cerebral blood flow in arteriosclerotic patients undergoing surgery |
PubMed
Title | Date | PubMed |
---|---|---|
Degradation of 2,4-dinitrophenol by two Rhodococcus erythropolis strains, HL 24-1 and HL 24-2. | 1992 Sep |
|
Effect of sludge-amendment or nutrient addition on the biodegradation of the herbicide isoproturon in soil. | 2001 Aug |
|
On-line estimation of the metabolic burden resulting from the synthesis of plasmid-encoded and heat-shock proteins by monitoring respiratory energy generation. | 2001 Dec |
|
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. | 2001 Feb |
|
[Sinusoidal modulated currents alone and in combination with carbon dioxide-hydrogen sulfide baths in juvenile rheumatoid arthritis]. | 2001 Jul-Aug |
|
Resonance Raman studies of the iron(II)--alpha-keto acid chromophore in model and enzyme complexes. | 2001 May 30 |
|
An indirect ELISA for detection of Encephalitozoon cuniculi infection in farmed blue foxes (Alopex lagopus). | 2002 |
|
Prevalence of fat embolism following bilateral simultaneous and unilateral total hip arthroplasty performed with or without cement : a prospective, randomized clinical study. | 2002 Aug |
|
Reduced natriuretic response to acute sodium loading in COMT gene deleted mice. | 2002 Aug 21 |
|
Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. | 2002 Dec |
|
[Study on the expression of E2 gene of classical swine fever virus in Pichia pastoris and the immunological activity of its expression product]. | 2002 Jan |
|
Gas-phase ozonolysis of alkenes: formation of OH from anti carbonyl oxides. | 2002 Jul 24 |
|
Site of nucleophilic attack and ring opening of five-membered heterocyclic 2,3-diones: a density functional theory study. | 2002 Oct 18 |
|
Acoustic attenuation in gas mixtures with nitrogen: experimental data and calculations. | 2003 Apr |
|
Mechanism of action of the diazabicyclononanone-type kappa-agonists. | 2003 Apr 10 |
|
Mutation induced modulation of hydrogen bonding to P700 studied using FTIR difference spectroscopy. | 2003 Aug 26 |
|
[Severe nephrotic syndrome in a young man taking anabolic steroid and creatine long term]. | 2003 Dec 7 |
|
Supercritical fluid processing of proteins: lysozyme precipitation from aqueous solution. | 2003 Feb |
|
Applications of laser-based ultrasonics to the characterization of the internal structure of teeth. | 2003 Jul |
|
[Effect of premedication on the formation of postoperative pain syndrome]. | 2003 Jul-Aug |
|
Laser-assisted uvulopalatoplasty for the treatment of snoring and mild obstructive sleep apnea syndrome. | 2003 Jun |
|
Occult supraglottic lymphatic malformation presenting as obstructive sleep apnea. | 2003 Mar |
|
Can preconditioning reduce laparoscopy-induced tissue injury? | 2003 May |
|
High-sensitivity photoacoustic leak testing. | 2003 Oct |
|
Identification of intramembrane hydrogen bonding between 13(1) keto group of bacteriochlorophyll and serine residue alpha27 in the LH2 light-harvesting complex. | 2003 Oct 17 |
|
Carbon-dioxide laser-assisted tonsil ablation for adults with chronic tonsillitis: a 6-month follow-up study. | 2003 Sep |
|
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma. | 2004 Dec |
|
Tretinoin treatment before carbon-dioxide laser resurfacing: a clinical and biochemical analysis. | 2004 Dec |
|
Isolation and characterization of a novel sphingomonad capable of growth with chrysene as sole carbon and energy source. | 2004 Dec 15 |
|
FTIR difference spectroscopy in combination with isotope labeling for identification of the carbonyl modes of P700 and P700+ in photosystem I. | 2004 Feb |
|
Lack of difference in the rates of hypopigmentation with 90-microsecond pulsed and longer dwell time carbon-dioxide laser resurfacing. | 2004 Feb |
|
CO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2. | 2004 Jan 20 |
|
Influence of the organophosphorus insecticide phosphamidon on lentic water. | 2004 Jul |
|
Supercritical carbon dioxide extraction of chamomile flowers: extraction efficiency, stability, and in-line inclusion of chamomile-carbon dioxide extract in beta-cyclodextrin. | 2004 Jul-Aug |
|
Hypoxia up-regulates triosephosphate isomerase expression via a HIF-dependent pathway. | 2004 May |
|
Role of tyrosine phosphorylation in sperm capacitation / acrosome reaction. | 2004 Nov 9 |
|
Photochemical preparation of highly functionalized 1-indanones. | 2004 Oct 29 |
|
Retention characteristics of porous graphitic carbon in subcritical fluid chromatography with carbon dioxide-methanol mobile phases. | 2004 Sep 3 |
|
Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model. | 2005 |
|
Coupling aggressive mass removal with microbial reductive dechlorination for remediation of DNAPL source zones: a review and assessment. | 2005 Apr |
|
Laryngeal amyloidosis. | 2005 Feb |
|
Angiokeratoma circumscriptum naeviforme: successful treatment with carbon-dioxide laser vaporization. | 2005 Feb |
|
A1 reduction in intact cyanobacterial photosystem I particles studied by time-resolved step-scan Fourier transform infrared difference spectroscopy and isotope labeling. | 2005 Feb 15 |
|
Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing. | 2005 Jan |
|
[Development of gastrotonometry and the future of its use in the monitoring of critically ill patients]. | 2005 Jan 23 |
|
Strong effects of an individual water molecule on the rate of light-driven charge separation in the Rhodobacter sphaeroides reaction center. | 2005 Jul 22 |
|
Differentiation of human bone marrow stem cells into cells with a neural phenotype: diverse effects of two specific treatments. | 2006 Feb 16 |
|
Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice. | 2006 Mar |
|
Characterisation of stationary phases in subcritical fluid chromatography with the solvation parameter model. III. Polar stationary phases. | 2006 Mar 31 |
Patents
Sample Use Guides
Carbon dioxide is usually administered through the lungs by inhalation. The major exceptions are when a metered supply is fed into the oxygenator of an extracorporeal circulation of a cardiopulmonary bypass system, and when the gas is used for laparoscopic surgery. As an additive to beverages, carbon dioxide is consumed orally.
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:39:24 GMT 2023
by
admin
on
Fri Dec 15 15:39:24 GMT 2023
|
Record UNII |
142M471B3J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
16551-4
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
13538-4
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
59165-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
28644-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
NDF-RT |
N0000180185
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
14640-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
51781-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
39465-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
77143-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
NDF-RT |
N0000010258
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2021-4
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2020-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
35685-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
13541-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
41647-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2018-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2028-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
39464-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
32306-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
JECFA EVALUATION |
INS-290
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-ATC |
A06AX02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
19212-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
CFR |
21 CFR 862.1160
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
39466-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-290
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
28645-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57920-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
53089-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
34520-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
48391-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2022-2
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
EPA PESTICIDE CODE |
16601
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2027-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
13540-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
11557-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
38253-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-VATC |
QA06AX02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
34728-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
14040-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57922-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
FDA ORPHAN DRUG |
465114
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57923-5
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2026-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
20565-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
DSLD |
3848 (Number of products:1)
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
53458-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57921-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
53090-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2019-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
19223-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
CFR |
21 CFR 184.1240
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2023-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-VATC |
QV03AN02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
11211-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
14003-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-ATC |
V03AN02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4256
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
100000076280
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
DB09157
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
124-38-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
DTXSID4027028
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
m3079
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
516
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
CHEMBL1231871
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
CARBON DIOXIDE
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
280
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
D002245
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
C65288
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
2034
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB13243MIG
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
16526
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
204-696-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
CARBON DIOXIDE (% Vol.)
Non-filtered cigarette(85 mm) Univ Kentucky- 9.4 Filtered cigarette(85 mm) New Yorl City- 9.6 Little cigars A(85 mm) Boston-8.5 Little cigars B (85 mm),New York City-13.2 Small cigars C(95 mm),New York City-12.7
|
||
|
SUB_CONCEPT->SUBSTANCE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
Unit: percent of total dose excreted (into Expired Air; 39.7% to 58.6%)
IN-VIVO
|
||
|
PARENT -> METABOLITE |
MAJOR
EXHALATION
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |